Communication in process of R&D and registration of new drugs of traditional Chinese medicine / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 730-735, 2021.
Article
in Zh
| WPRIM
| ID: wpr-878900
Responsible library:
WPRO
ABSTRACT
In recent years, the National Medical Products Administration has established a communication system for the process of drug R&D and registration. In this paper, the reform policies on establishing the communication system for drug evaluation in recent years were summarized, and the channels, processes, methods and types of communication were also collected. In addition, the communication status of new drugs of traditional Chinese medicine(TCM) was summarized according to the whole process of R&D, including summary of clinical practice, Investigational New Drug Applications, period of clinical trials, New Drug Applications, and post-marketing researches. Meanwhile, the current problems such as ineffective, inefficient, repeated or even no communication were analyzed, and relevant suggestions were proposed accordingly in order to provide reference for better communication on R&D and registration of new drugs of TCM.
Key words
Full text:
1
Database:
WPRIM
Main subject:
Drugs, Chinese Herbal
/
Pharmaceutical Preparations
/
Communication
/
Medicine, Chinese Traditional
Type of study:
Diagnostic_studies
Language:
Zh
Journal:
China Journal of Chinese Materia Medica
Year:
2021
Document type:
Article